LBP and sCD14 patterns in total hip replacement surgery performed during combined spinal/epidural anaesthesia

Scandinavian Journal of Clinical and Laboratory Investigation

Volumn 71, Issue 6, 2011, Pages 486-491

  Bastian, Daniel ^a   Tamburstuen, Margareth V ^b   Lyngstadaas, Ståle P ^b   Reikerås, Olav ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

Author keywords

hip prosthesis; Lipopolysaccharide binding protein; soluble CD14; surgery; trauma

Indexed keywords

BUPIVACAINE; CD14 ANTIGEN; CODEINE; FENTANYL; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIPOPOLYSACCHARIDE BINDING PROTEIN; MIDAZOLAM; PARACETAMOL;

ADULT; AGED; ARTICLE; BLEEDING; BONE; CLINICAL ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; EPIDURAL ANESTHESIA; FEMALE; HEMATOCRIT; HEMODILUTION; HIP ARTHROPLASTY; HIP OSTEOARTHRITIS; HUMAN; INNATE IMMUNITY; MALE; MUSCLE; POSTOPERATIVE PAIN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SPINAL ANESTHESIA;

ACUTE-PHASE PROTEINS; ADULT; AGED, 80 AND OVER; ANESTHESIA, EPIDURAL; ANESTHESIA, SPINAL; ANESTHETICS, LOCAL; ANTIGENS, CD14; ARTHROPLASTY, REPLACEMENT, HIP; BLOOD LOSS, SURGICAL; BLOOD VOLUME; BUPIVACAINE; C-REACTIVE PROTEIN; CARRIER PROTEINS; FEMALE; HUMANS; IMMUNITY, INNATE; INTERLEUKINS; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; OSTEOARTHRITIS, HIP; POSTOPERATIVE PERIOD; YOUNG ADULT;

BACTERIA (MICROORGANISMS); POSIBACTERIA;

EID: 80052943554     PISSN: 00365513     EISSN: 15027686     Source Type: Journal    
DOI: 10.3109/00365513.2011.587529     Document Type: Article

References (37)

1. Dimofte G, Alexander A, Carlson G, Little R, Irving M. TNF alpha and IL-6 involvement in surgical trauma. II. In vitro cytokine production. Rev Med Chir Soc Med Nat Iasi 2001;105:493-8.
2. Hassett S, Moynagh P, Reen D. TNF-alpha is a mediator of the anti-Inflammatory response in a human neonatal model of the non-septic shock syndrome. Pediatr Surg Int 2006; 22:24-30. (Pubitemid 43052195)
3. Ertel W, Kremer JP, Kenney J, Steckholzer U, Jarrar D, Trentz O, Schildberg FW. Downregulation of proInflammatory cytokine release in whole blood from septic patients. Blood 1995;85:1341-7.
4. Bulger EM, Cuschieri J, Warner K, Maier RV. Hypertonic resuscitation modulates the Inflammatory response in patients with traumatic hemorrhagic shock. Ann Surg 2007; 245:635-41. (Pubitemid 46555669)
5. Nau R, Eiffert H. Modulation of release of proInflammatory bacterial compounds by antibacterials: potential impact on course of Inflammation and outcome in sepsis and meningitis. Clin Microbiol Rev 2002;15:95-110. (Pubitemid 34052584)
6. Reikeras O, Sun J, Wang JE, Aasen AO. Postoperative serum attenuates LPS-induced release of TNF-alpha in orthopaedic surgery. J Orthop Res 2007;25:1395-400. (Pubitemid 47523370)
7. Reikeras O, Sun J, Wang JE, Foster SJ, Bastian D, Aasen AO. Immunmodulation of serum in orthopaedic trauma. J Trauma 2009;67:624-7.
8. Flohe SB, Bangen JM, Flohe S, Agrawal H, Bergmann K, Schade FU. Origin of immunomodulation after soft tissue trauma: potential involvement of extracellular heat-shock proteins. Shock 2007;27:494-502. (Pubitemid 46626076)
9. Lu YC, Yeh WC, Ohashi PS. LPS/TLR4 signal transduction pathway. Cytokine 2008;42:145-51.
10. Lamping N, Dettmer R, Schroder NW, Pfeil D, Hallatschek W, Burger R, Schumann RR. LPS-binding protein protects mice from septic shock caused by LPS or gram-negative bacteria. J Clin Invest 1998;101:2065-71. (Pubitemid 28244090)
11. Zweigner J, Gramm HJ, Singer OC, Wegscheider K, Schumann RR. High concentrations of lipopolysaccharidebinding protein in serum of patients with severe sepsis or septic shock inhibit the lipopolysaccharide response in human monocytes. Blood 2001;98:3800-8.
12. Kitchens RL, Thompson PA. Modulatory effects of sCD14 and LBP on LPS-host cell interactions. J Endotoxin Res 2005;11:225-9. (Pubitemid 41358857)
13. Hiki N, Berger D, Mimura Y, Frick J, Dentener MA, Buurman WA, Seidelmann M, Kaminishi M, Beger HG. Release of endotoxin-binding proteins during major elective surgery: role of soluble CD14 in phagocytic activation. World J Surg 2000;24:499-506. (Pubitemid 30210835)
14. Kudlova M, Kunes P, Kolackova M, Lonsky V, Mandak J, Andrys C, Jankovicova K, Krejsek J. Lipopolysaccharide binding protein and sCD14 are not produced as acute phase proteins in cardiac surgery. Mediators Inflamm 2007; 2007:72356.
15. Franke A, Lante W, Fackeldey V, Becker HP, Kurig E, Zoller LG, Weinhold C, Markewitz A. Pro-Inflammatory cytokines after different kinds of cardio-thoracic surgical procedures: is what we see what we know? Eur J Cardiothorac Surg 2005;28:569-75. (Pubitemid 41345246)
16. Bouter H, Schippers EF, Luelmo SA, Versteegh MI, Ros P, Guiot HF, Frolich M, van Dissel JT. No effect of preoperative selective gut decontamination on endotoxemia and cytokine activation during cardiopulmonary bypass: a randomized, placebo-controlled study. Crit Care Med 2002; 30:38-43. (Pubitemid 34112174)
17. Hiesmayr MJ, Spittler A, Lassnigg A, Berger R, Laufer G, Kocher A, Artemiou O, Boltz-Nitulescu G, Roth E. Alterations in the number of circulating leucocytes, phenotype of monocyte and cytokine production in patients undergoing cardiothoracic surgery. Clin Exp Immunol 1999;115:315-23. (Pubitemid 29052458)
18. Kawasaki T, Ogata M, Kawasaki C, Tomihisa T, Okamoto K, Shigematsu A. Surgical stress induces endotoxin hyporesponsiveness and an early decrease of monocyte mCD14 and HLA-DR expression during surgery. Anesth Analg 2001;92:1322-6. (Pubitemid 32385966)
19. Bastian D, Shegarfi H, Rolstad B, Naper C, Lyngstadaas SP, Reikeras O. Investigation of lipopolysaccharide receptor expression on human monocytes after major orthopaedic surgery. Eur Surg Res 2008;40:239-45. (Pubitemid 351252934)
20. Muller R, Mellors I, Johannessen B, Aarsand AK, Kiefer P, Hardy J, Kendall R, Scott CS. European multi-center evaluation of the Abbott Cell-Dyn sapphire hematology analyzer. Lab Hematol 2006;12:15-31.
21. Fevang BT, Lie SA, Havelin LI, Engesæ t er LB, Furnes O. Improved results of primary total hip replacement. Acta Orthop 2010;81:649-59.
22. Beutler B. TLR4 as the mammalian endotoxin sensor. Curr Top Microbiol Immunol 2002;270:109-20. (Pubitemid 35448156)
23. Medzhitov R. Toll-like receptors and innate immunity. Nat Rev Immunol 2001;1:135-45. (Pubitemid 33741967)
24. Schroder NW, Schumann RR. Non-LPS targets and actions of LPS binding protein (LBP). J Endotoxin Res 2005;11:237-42. (Pubitemid 41358859)
25. Wurfel MM, Kunitake ST, Lichenstein H, Kane JP, Wright SD. Lipopolysaccharide (LPS)-binding protein is carried on lipoproteins and acts as a cofactor in the neutralization of LPS. J Exp Med 1994;180:1025-35. (Pubitemid 24256615)
26. Dentener MA, Vreugdenhil AC, Hoet PH, Vernooy JH, Nieman FH, Heumann D, Janssen YM, Buurman WA, Wouters EF. Production of the acute-phase protein lipopolysaccharide- binding protein by respiratory type II epithelial cells: implications for local defense to bacterial endotoxins. Am J Respir Cell Mol Biol 2000;23:146-53. (Pubitemid 30656422)
27. Maes M, Scharpe S, Meltzer HY, Bosmans E, Suy E, Calabrese J, Cosyns P. Relationships between interleukin-6 activity, acute phase proteins, and function of the hypothalamicpituitary- adrenal axis in severe depression. Psychiatry Res 1993;49:11-27. (Pubitemid 23329244)
28. Song C, Leonard BE. Interleukin-2-induced changes in behavioural, neurotransmitter, and immunological parameters in the olfactory bulbectomized rat. Neuroimmunomodulation 1995;2:263-73. (Pubitemid 26150653)
29. Bjornsson GL, Thorsteinsson L, Gudmundsson KO, Jonsson H, Jr., Gudmundsson S, Gudbjornsson B. Inflammatory cytokines in relation to adrenal response following total hip replacement. Scand J Immunol 2007;65:99-105. (Pubitemid 44968078)
30. Ng PML, Zhenxiao J, Tan SSH, Ho B, Ding JL. C-reactive protein: a predominant LPS-binding acute phase protein responsive to Pseudomonas infection. J Endotoxin Res 2004;10:163-74. (Pubitemid 38877736)
31. Schumann RR, Leong SR, Flaggs GW, Gray PW, Wright SD, Mathison JC, Tobias PS, Ulevitch RJ. Structure and function of lipopolysaccharide binding protein. Science 1990;249: 1429-31. (Pubitemid 120034117)
32. Mathison JC, Tobias PS, Wolfson E, Ulevitch RJ. Plasma lipopolysaccharide (LPS)-binding protein. A key component in macrophage recognition of gram-negative LPS. J Immunol 1992;149:200-6.
33. Bas S, Gauthier BR, Spenato U, Stingelin S, Gabay C. CD14 is an acute-phase protein. J Immunol 2004;172: 4470-9. (Pubitemid 38375263)
34. Schumann RR, Kirschning CJ, Unbehaun A, Aberle HP, Knope HP, Lamping N, Ulevitch RJ, Herrmann F. The lipopolysaccharide-binding protein is a secretory class 1 acute-phase protein whose gene is transcriptionally activated by APRF/STAT/3 and other cytokine-inducible nuclear proteins. Mol Cell Biol 1996;16:3490-503. (Pubitemid 26199868)
35. Pugin J, Heumann ID, Tomasz A, Kravchenko VV, Akamatsu Y, Nishijima M, Glauser MP, Tobias PS, Ulevitch RJ. CD14 is a pattern recognition receptor. Immunity 1994;1:509-16.
36. Kol A, Lichtman AH, Finberg RW, Libby P, Kurt-Jones EA. Cutting edge: heat shock protein (HSP) 60 activates the innate immune response: CD14 is an essential receptor for HSP60 activation of mononuclear cells. J Immunol 2000; 164:13-7. (Pubitemid 30012965)
37. Deitch EA. Multiple organ failure. Pathophysiology and potential future therapy. Ann Surg 1992;216:117-34.